Thomas McCauley - 07 Feb 2024 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGAQ)

Signature
/s/ Barbara Chan as Attorney-in-Fact for Thomas McCauley
Issuer symbol
OMGAQ
Transactions as of
07 Feb 2024
Net transactions value
$0
Form type
4
Filing time
09 Feb 2024, 17:14:52 UTC
Previous filing
02 Mar 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMGA Stock Option (Right to Buy) Award $0 +125,000 $0.000000 125,000 07 Feb 2024 Common Stock 125,000 $3.59 Direct F1
transaction OMGA Stock Option (Right to Buy) Award $0 +75,000 $0.000000 75,000 07 Feb 2024 Common Stock 75,000 $3.59 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable with respect to 25% of the underlying shares on February 7, 2025 and in twelve (12) equal quarterly installments thereafter such that the option will become fully vested and exercisable on February 7, 2028, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
F2 The option vests and becomes exercisable in three equal installments on each of October 7, 2024, June 7, 2025 and February 7, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date.